CLINICAL_TRIALS
trial_result
· 2012-01-13
Clinical Trial Update: Imatinib Mesylate in Treating Patients With Myelofibrosis [Phase 2]
Summary
Phase 2 trial evaluating imatinib mesylate in patients with primary myelofibrosis. The study was terminated and results were posted in January 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: OHSU Knight Cancer Institute | Conditions: Chronic Myeloproliferative Disorders | Phase 2 | Status: TERMINATED | Results posted: 2012-01-13